The report " Global Active Pharmaceutical Ingredient Market, By Type (Generic and Branded), By Business Mode (Captive API and Merchant API), By Synthesis Type (Synthetic and Biotech), By Application (Cardiology, Pulmonology, Oncology, Ophthalmology, Neurology, and Orthopedic), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029’
Key Highlights:
• In 2020, Pfizer (US) signed a multiyear agreement with Gilead Sciences to manufacture and supply Gilead’s antiviral drug (Remdesivir) for the treatment of COVID-19.
• In April 2020, Boehringer Ingelheim (Germany) acquired Northern Biologics, which focuses on therapeutic antibodies targeting the tumor microenvironment. This acquisition broadened Boehringer Ingelheim’s oncology product portfolio.
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Active...
Key Market Insights from the report:
The Global Active Pharmaceutical Ingredient Market accounted for US$ 164.89 billion in 2020 and is estimated to be US$ 339.08 million by 2030 and is anticipated to register a CAGR of 7.5%. The Global Active Pharmaceutical Ingredient Market is segmented based on the type, business mode, synthesis type, application and region.
• By Type, the market is segmented into Generic and Branded.
• By Business mode, the Global Active Pharmaceutical Ingredient Market is segmented into Captive API and Merchant API.
• By Synthesis Type, the market is segmented into Synthetic and Biotech.
• By Application, the market is segmented into Cardiology, Pulmonology, Oncology, Ophthalmology, Neurology, and Orthopedic.
• By Region, the Global Active Pharmaceutical Ingredient Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2019, North America is anticipated to dominate the global market, followed by Europe.
Competitive Landscape:
The key players operating in the global Active Pharmaceutical Ingredient market includes Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer, Inc., Bristol-Myers Squibb, Novartis AG, Boehringer Ingelheim, GlaxoSmithKline plc., Eli Lilly and Company, AbbVie Inc., and Merck & Co., Inc. Technological advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global market.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
Contact Us:
Sales
Prophecy Market Insights
Email- [email protected]